Our data suggest that GDF15 plays a role in cardiac cachexia, and GDF15 neutralization could potentially be an effective therapeutic approach for the treatment of cachexia in HF or other chronic diseases with elevated GDF15, such as COPD, CKD, and cancer. This evidence concerns the gene GDF15 and chronic kidney disease.